Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Revenue

Jilin Aodong Pharmaceutical Group had revenue of 513.94M CNY in the quarter ending September 30, 2025, with 3.25% growth. This brings the company's revenue in the last twelve months to 2.34B, down -22.08% year-over-year. In the year 2024, Jilin Aodong Pharmaceutical Group had annual revenue of 2.61B, down -24.31%.

• Revenue (ttm): 2.34B
• Revenue Growth: -22.08%
• P/S Ratio: 9.45
• Revenue / Employee: 407.55K
• Employees: 5,454
• Market Cap: 22.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.61B	-838.55M	-24.31%
Dec 31, 2023	3.45B	580.91M	20.25%
Jan 1, 2023	2.87B	564.45M	24.50%
Jan 1, 2022	2.30B	52.11M	2.31%
Dec 31, 2020	2.25B	-836.73M	-27.09%